RxDoctor Payments Data

Nancy Townsend O'Day

Nurse Practitioner · Millsboro, DENPI 1063652261

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.9% of the total across 363 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,969in general payments, 2019–2025

Across 363 payments — averaging $21.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • Lilly USA, LLC$2K
  • AbbVie$1K
  • Pfizer$510
  • Sun Pharmaceutical Industries Inc.$428
  • E.r. Squibb & Sons, L.L.C.$411
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$7,24391%
  • Education$7269%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,969 in reported general payments places this provider in the 95th percentile of 487 nurse practitioner providers in Delaware.

See all nurse practitioner providers in Delaware

Medicare billing

Part B allowed, 2024
$519,389
Medicare patients
1,245
Services billed
33,194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab12$102,602
Taltz SyringeIxekizumab11$76,698
Metronidazole92$5,625
Clobetasol Propionate77$3,100
Ketoconazole69$1,623
Imiquimod43$1,412
Triamcinolone Acetonide126$1,282
Ammonium Lactate41$944
NyamycNystatin34$902
Doxycycline Hyclate32$805
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip29$737
Clindamycin Phosphate24$620
Ursodiol12$478
NystopNystatin20$454
ValacyclovirValacyclovir Hcl13$366

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Millsboro

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →